Deanna Broderick
About Deanna Broderick
Deanna Broderick is the Senior Manager of Compliance Cell Therapy at Bristol Myers Squibb in Massachusetts, with extensive experience in quality assurance and compliance roles across various pharmaceutical companies.
Current Position at Bristol Myers Squibb
Deanna Broderick is currently serving as Senior Manager, Compliance Cell Therapy at Bristol Myers Squibb in Massachusetts, United States. In this role, she leverages her extensive experience in compliance and quality assurance to uphold regulatory standards and ensure adherence to manufacturing protocols.
Previous Roles at Kite Pharma
Deanna Broderick worked at Kite Pharma as a Senior Quality Compliance Analyst, Global Compliance from 2020 to 2021 in Santa Monica, California. Prior to that, she served as Specialist II, Quality Systems from 2019 to 2020. During her time at Kite Pharma, she contributed to the compliance and quality systems, reinforcing the company's commitment to maintaining high standards in its operations.
Experience at Aegerion Pharmaceuticals
From 2017 to 2019, Deanna Broderick worked at Aegerion Pharmaceuticals, first as a Quality Assurance Specialist and later as a Senior Quality Assurance Specialist in Cambridge, Massachusetts. Over these two years, she was involved in ensuring the quality and compliance of pharmaceutical products, applying her expertise in quality assurance.
Early Career at Sanofi Genzyme and Shire
Deanna Broderick began her career at Sanofi Genzyme, holding multiple roles from 2011 to 2016, including QS Documentation Specialist Lead and QA Compliance Specialist. She then moved on to work as a QC Investigator in the Product Testing Group at Shire from 2016 to 2017 in Lexington, Massachusetts. These positions helped her build a solid foundation in quality control and compliance.
Education and Technical Skills
Deanna Broderick holds a Master of Science of Management in Biopharmaceutical Leadership from Emmanuel College (2011-2013) and a Bachelor of Science in Biology from the same institution (2006-2010). She possesses excellent technical writing skills, a solid understanding of CGMP environments, and extensive experience in deviation/nonconformance identification and resolution. Her education and skills are critical in her current role and previous positions.